Company Overview

UNITED THERAPEUTICS CORP

UTHR
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
3,183M
2025 FY
Net Income
1,335M
2025 FY
Shares Outstanding
44M
2025 FY
EPS
30.13USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1082554
Exchange
Nasdaq
Location
US